| CAS: | 74150-27-9 | ||||
| 分子式: | C19H18N4O2 | ||||
| 分子量: | 334.37 | ||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||
| P793210 | MACKLIN | 匹莫苯丹 | 10mM in DMSO | 820元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| P854979 | MACKLIN | 匹莫苯丹 | 97% | 110元/250mg; 287元/1g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存: -20°C 状态:白色到微黄色粉末,晶体或颗粒 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| P2779 | TCI | Pimobendan | >98.0%(T)(HPLC) | 990元/50MG; 2990元/250MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000401 | Pimobendan for system suitability | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 0.1 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| SML1333 | Sigma-Aldrich | Pimobendan | ≥98% (HPLC) | 1396.09元/10 MG; 4498.97元/50 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 包装 10, 50 mg in glass bottle 生化/生理作用 Pimobendan is an inotropic agent with a dual mechanism of action: it increases myocardial contractility by increasing calcium sensitization to troponin C and it promotes vasodilation by inhibiting phosphodiesterase III (PDE3). Pimobendan has been studied for treating heart failure and cardiomyopathy, primarily for veterinary uses. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR3084 | Supelco | Pimobendan | pharmaceutical secondary standard, certified reference material | 6012.33元/200 mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1569315 | USP | Pimobendan | United States Pharmacopeia (USP) Reference Standard | 23017.6元/100 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP1247 | Pimobendan | British Pharmacopoeia (BP) Reference Standard | 2299.24元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||